A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT 1 receptors-Reference-Cited by-同舟云学术

A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT 1 receptors

Published:2019-12-12 Issue:2 Volume:177 Page:402-419
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Wu Hailang¹²³,Wang Yiyi¹²³,Wang Gongxin⁴,Qiu Zhihua¹²³,Hu Xiajun¹²³,Zhang Hongrong¹²³,Yan Xiaole¹²³,Ke Fan¹²³,Zou Anruo⁴,Wang Min¹²³,Liao Yuhua¹²³,Chen Xiao¹²³^ORCID

Affiliation:

1. Department of Cardiology, Union Hospital, Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China

2. Institute of Cardiology, Union Hospital, Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China

3. Key Lab for Biological Targeted Therapy of Education Ministry and Hubei Province, Union Hospital, Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China

4. Electrophysiological LaboratoryQingdao Haiwei Biopharma Co. Ltd Qingdao China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14875

Reference56 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors

2. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors